[Updated German Clinical Practice Guideline on "Diagnosis and treatment of Crohn's disease" 2014].
[Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain.]
Prevalence of Chronic Disabling Non - cancer Pain and Associated Demographic and Medical Variables: A Cross-sectional Survey in the General German Population.
[Opioids in chronic neuropathic pain : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.]
[Opioids in chronic noncancer pain-are opioids different? : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids of at least four week's duration.]
[Opioids in chronic noncancer pain-are opioids superior to nonopioid analgesics? : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized head-to-head comparisons of opioids versus nonopioid analgesics of at least four week's duration.]
[Opioids in chronic osteoarthritis pain : A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration.]
[Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany. Results of a representative population survey].
Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum.
Long-term opioid use in non-cancer pain.
Fibromyalgia syndrome: a somatoform disorder?
Fibromyalgia and physical trauma: the concepts we invent.
Social security work disability and its predictors in patients with fibromyalgia.
The impact of body weight and depression on low back pain in a representative population sample.
What is fibromyalgia, how is it diagnosed, and what does it really mean?
[S2k guidelines diverticular disease/diverticulitis].
Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis.
[Visceral pain. Still a poor relation of pain medicine?].
[Chronic chest pain].
[Prevalence of disabling abdominal pain and menstrual cramp. Results from a representative survey of the general German population].
Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: A review.
Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: a review.
Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings.
[Treatment of non-specific, functional and somatoform bodily complaints].
Validation of the Patient-Doctor-Relationship Questionnaire (PDRQ-9) in a representative cross-sectional German population survey.
Complementary and alternative medicine for the treatment of fibromyalgia.
Symptoms, the nature of fibromyalgia, and diagnostic and statistical manual 5 (DSM-5) defined mental illness in patients with rheumatoid arthritis and fibromyalgia.
Untying chronic pain: prevalence and societal burden of chronic pain stages in the general population - a cross-sectional survey.
Review of pharmacological therapies in fibromyalgia syndrome.
The first Israeli fibromyalgia congress, February 2013.
[Fibromyalgia syndrome - updated s3 guidelines].
The Somatic Symptom Disorder in DSM 5 risks mislabelling people with major medical diseases as mentally ill.
Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study.
Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome.
[Administrative prevalence, treatment and costs of somatoform pain disorder. Analysis of data of the BARMER GEK for the years 2008-2010].
[Are members of fibromyalgia syndrome self-help groups "different"? Demographic and clinical characteristics of members and non-members of fibromyalgia syndrome self-help groups].
[Mental disorders in patients with fibromyalgia syndrome: screening in centres of different medical specialties].
Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis.
[The childhood trauma screener (CTS) - development and validation of cut-off-scores for classificatory diagnostics].
Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.
Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia.
[Prevalence of chronic pain in Germany. A representative survey of the general population].
[Validation and first results of the German QUOTE-IBD to measure quality of care from the perspective of patients with inflammatory bowel disease].
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
Quality of life in coeliac patients: Italian validation of a coeliac questionnaire.
[New guidelines on functional and somatoform disorders].
Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials.
Patient-related predictors of treatment satisfaction of patients with fibromyalgia syndrome: results of a cross-sectional survey.
The association among childhood maltreatment, somatic symptom intensity, depression, and somatoform dissociative symptoms in patients with fibromyalgia syndrome: a single-center cohort study.
Spa treatment (balneotherapy) for fibromyalgia-a qualitative-narrative review and a historical perspective.
Efficacy of EMG- and EEG-Biofeedback in Fibromyalgia Syndrome: A Meta-Analysis and a Systematic Review of Randomized Controlled Trials.
Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines.
[Fibromyalgia syndrome as a psychosomatic disorder - diagnosis and therapy according to current evidence-based guidelines].
Anticonvulsants for fibromyalgia.
Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
Cognitive behavioural therapies for fibromyalgia.
Frequency of child maltreatment in a representative sample of the German population.
Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies.
A systematic review and meta-analysis of qigong for the fibromyalgia syndrome.
Widespread pain in older Germans is associated with posttraumatic stress disorder and lifetime employment status--results of a cross-sectional survey with a representative population sample.
Non-specific, functional, and somatoform bodily complaints.
[Fibromyalgia syndrome guideline: Interim assessment].
[Methodological fundamentals of the development of the guideline].
[Definition, diagnosis and therapy of chronic widespread pain and so-called fibromyalgia syndrome in children and adolescents. Systematic literature review and guideline].
[Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].
[Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
[Psychotherapy for patients with fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
[Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
[Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
[Fibromyalgia syndrome. General principles and coordination of clinical care and patient education].
[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
[Etiology and pathophysiology of fibromyalgia syndrome].
Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.
Nocebo phenomena in medicine: their relevance in everyday clinical practice.
[German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].
[Prevalence and predictors of urogenital pain in men. Results from a survey of a representative German population sample].
The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis.
[Never say: "it's nothing. Improving care for patients with non-specific, functional and somatoform bodily complaints].
Functional bowel disorders in adults.
[The German Version of the Childhood Trauma Questionnaire (CTQ): psychometric characteristics in a representative sample of the general population].
Correspondence (reply): In Reply.
Hearing loss in fibromyalgia? Somatic sensory and non-sensory symptoms in patients with fibromyalgia and other rheumatic disorders.
The German fibromyalgia consumer reports - a cross-sectional survey.
Is the association of self-reported childhood maltreatments and adult fibromyalgia syndrome attributable to depression? A case control study.
Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey.
Diagnosis and diagnostic tests for fibromyalgia (syndrome).
Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.
[Placebo responders in randomized controlled drug trials of fibromyalgia syndrome : Systematic review and meta-analysis].
Fibromyalgia diagnosis and diagnostic criteria.
A comparison of the clinical features of fibromyalgia syndrome in different settings.
The longitudinal outcome of fibromyalgia: a study of 1555 patients.
[Treatment and healthcare costs of fibromyalgia syndrome in Germany: analysis of the data of the Barmer health insurance (BEK) from 2008-2009].
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot study.
Systematic review: Placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy-magnitude and patient-related predictors.
[Diagnosis and therapy of fibromyalgia syndrome].
Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis.
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia.
Maltreatment in childhood and adolescence: results from a survey of a representative sample of the German population.
Demographic and clinical features of patients with fibromyalgia syndrome of different settings: a gender comparison.
Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.
The development of fibromyalgia--I: examination of rates and predictors in patients with rheumatoid arthritis (RA).
Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population.
Efficacy of hypnosis/guided imagery in fibromyalgia syndrome--a systematic review and meta-analysis of controlled trials.
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome.
Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials.
[Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings].
[Diagnostic evaluation of chronic pelvic pain]
[Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome].
Anxiety and depression in adult patients with celiac disease on a gluten-free diet.
Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Efficacy of acupuncture in fibromyalgia syndrome--a systematic review with a meta-analysis of controlled clinical trials.
Guidelines on the management of fibromyalgia syndrome - a systematic review.
Diagnosis of fibromyalgia syndrome-a comparison of Association of the Medical Scientific Societies in Germany, survey, and American College of Rheumatology criteria.
Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials.
A cluster within the continuum of biopsychosocial distress can be labeled "fibromyalgia syndrome"--evidence from a representative German population survey.
Qualitative systemic review of randomized controlled trials on complementary and alternative medicine treatments in fibromyalgia.
[Fibromyalgia syndrome: what antidepressants cannot do].
[Prevalence and predictors of pain in several body regions. Results of a representative German population survey].
Correspondence (reply): In Reply.
[Fibromyalgia syndrome: diagnostic criteria and treatment].
Efficacy of hydrotherapy in fibromyalgia syndrome--a meta-analysis of randomized controlled clinical trials.
Treatment of fibromyalgia syndrome with gabapentin and pregabalin--a meta-analysis of randomized controlled trials.
[Intensity of limb pain and fatigue in fibromyalgia syndrome, depressive disorders and chronic back pain. A criterion for differentiation].
Fibromyalgia syndrome: classification, diagnosis, and treatment.
[Diagnosis and therapy of fibromyalgia syndrome].
Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials.
Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis.
[Definition, classification and diagnosis of fibromyalgia syndrome].
[Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings].
[Clinical practice guideline on diagnosis and treatment of Crohn's disease].
A systematic review on the effectiveness of treatment with antidepressants in fibromyalgia syndrome.
[Fibromyalgia syndrome: guideline principle for a fiction?].
[Physiotherapy, exercise and strength training and physical therapies in the treatment of fibromyalgia syndrome].
[Psychotherapy in patients with fibromyalgia syndrome].
[Methodological fundamentals for the development of the guideline].
[Aims of the guidelines for diagnostic and treatment of fibromyalgia syndrome].
[Multicomponent therapy for treatment of fibromyalgia syndrome].
[Alternative and complementary therapies in fibromyalgia syndrome].
[Juvenile fibromyalgia syndrome].
[Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].
[Definition, classification and diagnosis of fibromyalgia syndrome].
[Pharmacological treatment of fibromyalgia syndrome].
New treatment options for fibromyalgia: critical appraisal of duloxetine.
[Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain].
Psychophysiology of visceral pain in IBS and health.
Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety.
[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].
Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.
Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts.
[Self-assessed pain intensity and disability in subjects diagnosed with fibromyalgia claiming retirement pension]
[Fibromyalgia syndrome. Rheumatic disease or a mental disorder?]
[Pain and consciousness. Articles from the summer workshop held by the German Interdisciplinary Collaboration for Pain Therapy (DIVS) in 2005]
Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease.
Predictors of reduced health-related quality of life in adults with coeliac disease.
Development and validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease.
Health-related quality of life in adult coeliac disease in Germany: results of a national survey.
[Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)].
[Causal illness attributions and healthcare utilization in fibromyalgia syndrome]
[Fibromyalgia -- a somatoform (pain) disorder?]
[The influence of psychiatric comorbidity on the length of hospital stay of medical inpatients within the German Diagnosis Related Groups System].
Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats.
[Frequency, relevance, causes of and strategies for prevention of medication errors].
Mental disorder and psychologic distress in patients with ulcerative colitis after ileal pouch-anal anastomosis.
[Is an evidence-based therapy of inpatients with type 2 diabetes possible from studies used for formulating therapy guidelines?]
[Fibromyalgia in the legal procedures of the german sozialgericht -- psychosocial risk factors and predictors of health care utilization].
[Comorbidity of internal inpatients in the german diagnosis related groups-system].
Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study.
[Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) -- first application and comparison with international investigations]
Biopsychosocial determinants of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis.
Questions on life satisfaction (FLZM) in inflammatory bowel disease.
Validation of the German version of the Chronic Liver Disease Questionnaire.
[Chronic abdominal pain--internistic-psychosomatic aspects]
[Functional somatic pain syndromes]
[Functional somatic pain syndromes-nomenclature]
[Irritable bowel syndrome]
[Functional somatic pain syndromes: summary of hypotheses of their overlap and etiology]
[Dysfunctional syndromes: their diagnostics and treatment]
[About the article from Madisch A et al. Impact of reflux disease on general and disease-related quality of life--evidence from a recent comparative methodological study in Germany. Z.Gastroenterol 2003;41:1137-1143].
Expression of kinin receptor mRNA in the HPA axis of type 1 and type 2 diabetic rats.
Determinants of health-related quality of life in patients with chronic liver diseases.
Validation of the inflammatory bowel disease questionnaire IBDQ-D, German version, for patients with ileal pouch anal anastomosis for ulcerative colitis.
[Cost effectiveness of integrated internal medicine].
Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C.
Internal psychosomatic medicine within the German Diagnosis Related Groups System.
Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors.
[The effectiveness of adjunctive hypnosis with surgical patients. A meta-analysis]
[Validation of a German Version of the Fatigue Impact Scale FIS-D]
[Dosage equivalents of AT1-receptor antagonists available in Germany].
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension.
[Hypnosis in gastroenterology]
Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY.
Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors.
Kinin B2 receptor localization and expression in the hypothalamo-pituitary-adrenal axis of spontaneously hypertensive rats.
[Psychophysiology of visceral pain syndromes]
[Diagnostic criteria and therapeutic strategies of abdominal pain syndromes]
[Visceral pain--a neglected phenomenon in pain therapy and research?]
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
[Tobacco associated gastrointestinal disorders: smoking cessation therapy - a task for gastroenterologists]
Increased angiotensin II AT(1) receptor expression in paraventricular nucleus and hypothalamic-pituitary-adrenal axis stimulation in AT(2) receptor gene disrupted mice.
[Medical expertise of chronic pain syndromes by psychotherapists]
[Nicotine dependence and motivation for smoking cessation in patients of a cardiologic-pneumologic department].
[Colitis ulcerosa and opioid addiction]
[Efficacy of hypnosis in treatment of pain. A meta-analysis of hypnosis-induced analgesia: how effective is hypnosis?]
Kinin B1 and B2 receptor mRNA expression in the hypothalamus of spontaneously hypertensive rats.
[Smoking cessation. A physician's responsibility]
Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice.
[Hypnosis in medical practice. A healing method or quackery? (interview by Dipl.-Biol. Waldtraud Paukstadt)]
[Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases]
[Increased demand for psychosomatic consultation service (C-service) in a department of cardiology/pneumology due to psychometric screening]
[Measuring quality of life in gastroenterology--concepts, instruments and problems]
Angiotensin-converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats.
Increased AT(1) receptor expression and mRNA in kidney glomeruli of AT(2) receptor gene-disrupted mice.
[Prospective epidemiological study of epigastric complaints (PRESTO)]
[Comment on consensus report: Irritable bowel syndrome--definition, verifying the diagnosis, pathophysiology and therapeutic options]
Gerbil angiotensin II AT1 receptors are highly expressed in the hippocampus and cerebral cortex during postnatal development.
Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system.
[Four minutes for the patient and one minute for the families. Physician-patient-family communication in medical departments]
Ischemia-induced neuronal cell loss is associated with loss of atypical angiotensin type-1 receptor expression in the gerbil hippocampal formation.
Chemical lesion of the inferior olive reduces [125I]sarcosine1-angiotensin II binding to AT2 receptors in the cerebellar cortex of young rats.
Characterization and distribution of angiotensin II receptor subtypes in the mouse brain.
Effects of the AT1 antagonist HR 720 in comparison to losartan on stimulated sympathetic outflow, blood pressure, and heart rate in pithed spontaneously hypertensive rats.
The angiotensin AT1 receptor antagonist CV-11974 regulates cerebral blood flow and brain angiotensin AT1 receptor expression.
Water deprivation upregulates ANG II AT1 binding and mRNA in rat subfornical organ and anterior pituitary.
Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus.
[Pain management in patients with chronic rheumatic pain--a model for primary medical care]
[Diagnosis and therapy of functional dyspepsia]
[Sports and the digestive tract]
[Psychosomatic aspects of Crohn disease]
[Psychosomatics and epistemology. Principles and changes in the concept of psychosomatics]